AQUESTIVE THERAPEUTICS INC (AQST)
US03843E1047 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 95.20M | 23.87M | 27.27M | 28.02M | 31.81M | |||
| Receivables | 8.32M | 8.47M | 4.70M | 12.12M | 6.96M | |||
| Inventories | 7.73M | 6.77M | 5.78M | 4.04M | 2.46M | |||
| Other Current Assets | 2.12M | 1.85M | 2.13M | 3.08M | 3.40M | |||
| Total Current Assets | 113.38M | 40.97M | 39.89M | 47.26M | 44.63M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.49M | 9.74M | 9.30M | 7.78M | 10.32M | |||
| Intangibles | 1.24M | 1.28M | 1.44M | 50.00K | 100.00K | |||
| Other Non-Current Assets | 1.42M | 1.44M | 1.45M | 900.00K | 840.00K | |||
| Total Non-Current Assets | 16.14M | 16.45M | 17.18M | 14.73M | 18.25M | |||
| TOTAL ASSETS | 129.52M | 57.42M | 57.07M | 61.99M | 62.88M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 23.00K | 22.00K | 18.70M | 2.03M | 2.58M | |||
| Accrued Expenses | 5.05M | 6.89M | 8.22M | 9.64M | 9.30M | |||
| Accounts Payable | 10.52M | 8.93M | 9.95M | 8.31M | 7.09M | |||
| Other Current Liabilities | 2.46M | 2.47M | 2.66M | 1.99M | 2.14M | |||
| Total Current Liabilities | 18.06M | 18.31M | 39.53M | 21.96M | 21.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 28.76M | 27.51M | 33.45M | 51.55M | 34.33M | |||
| Other Non-Current Liabilities | 119.01M | 118.09M | 102.65M | 70.61M | 55.95M | |||
| Total Non-Current Liabilities | 147.77M | 145.60M | 136.09M | 122.17M | 90.28M | |||
| TOTAL LIABILITIES | 165.82M | 163.91M | 175.62M | 144.13M | 111.38M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -331.90M | -319.08M | -311.21M | -256.80M | -186.26M | |||
| Additional Paid In Capital | 295.51M | 212.52M | 192.60M | 174.62M | 137.73M | |||
| Common Shares | 90.00K | 69.00K | 60.00K | 40.00K | 40.00K | |||
| Shares Outstanding | 90.48M | 68.53M | 54.83M | 41.23M | 34.57M | |||
| Tangible Book Value per Share | -0.41 | -1.57 | -2.19 | -1.99 | -1.41 | |||
| Total Shareholders' Equity | -36.30M | -106.49M | -118.55M | -82.13M | -48.50M | |||
| TOTAL LIABILITIES AND EQUITY | 129.52M | 57.42M | 57.07M | 61.99M | 62.88M | |||
| Statistics | ||||||||
| Debt/Equity | -0.79 | -0.26 | -0.28 | -0.63 | -0.71 | |||
| Current Ratio | 6.28 | 2.24 | 1.01 | 2.15 | 2.12 | |||
| Return On Assets (ROA) | -22.21% | -13.71% | -95.34% | -113.79% | -88.71% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD